Form 4: Solen Therapeutics Executive Sells Shares to Cover Tax Obligations

Kristen Yen, a Senior Vice President at Soleno Therapeutics, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On April 1, 2024, Kristen Yen, Senior Vice President, Clinical Operations at Soleno Therapeutics Inc., sold 1,330 shares of common stock at a weighted average price of $41.1227.
• Another sale of 888 shares occurred on the same day at a weighted average price of $41.6671.
• These sales were executed to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
• Following these transactions, Yen directly owns 23,422 shares of Soleno Therapeutics common stock, some of which are RSUs representing a contingent right to receive one share of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing simply reports stock sales for tax obligations, a routine event.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is important for investors to monitor.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely minimal given the relatively small number of shares sold.

Key Dates